Send to

Choose Destination
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3758-3764. doi: 10.1080/21691401.2019.1666864.

CTRP3 inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells.

Author information

Department of Ophthalmology, Shaanxi Provincial People's Hospital , Xi'an , China.
Department of Obstetrics, First Affiliated Hospital of Xi'an Medical College , Xi'an , China.


Diabetic retinopathy (DR) is one of the most common diabetic complications and remains the leading cause of vision loss among adults. C1q/TNF-related protein 3 (CTRP3) is a member of CTRP family that has been found to be involved in the progression of diabetes mellitus and diabetic complications. However, the role of CTRP3 in DR has not been fully understood. In the present study, the results showed that CTRP3 expression was significantly decreased in DR patients compared with controls. In vitro investigations proved that overexpression of CTRP3 improved cell viability of ARPE-19 cells in response to high glucose (HG) stimulation. CTRP3 also attenuated HG-induced oxidative stress in ARPE-19 cells with decreased levels of reactive oxygen species (ROS) and malondialdehyde (MDA), and increased superoxide dismutase (SOD) activity. Apoptotic rate was significantly decreased in CTRP3 overexpressing ARPE-19 cells. Besides, bcl-2 expression was increased, while bax expression was decreased by CTRP3 overexpression. Moreover, overexpression of CTRP3 enhanced the activation of nuclear factor erythroid 2-related factor 2 (Nrf2)/hemeoxygenase-1 (HO-1) pathway in HG-stimulated ARPE-19 cells, and Nrf2 knockdown reversed CTRP3-mediated oxidative stress and apoptosis. These findings suggested that CTRP3 attenuated HG-stimulated oxidative stress and apoptosis in ARPE-19 cells, which were mediated by activation of Nrf2/HO-1 pathway.


C1q/TNF-related protein 3 (CTRP3); Diabetic retinopathy (DR); Nrf2/HO-1 pathway; high glucose (HG); oxidative stress

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center